Abstract
Organoids have been an exciting advancement in stem cell research. Here we describe a strategy for directed differentiation of human pluripotent stem cells into distal lung organoids. This protocol recapitulates lung development by sequentially specifying human pluripotent stem cells to definitive endoderm, anterior foregut endoderm, ventral anterior foregut endoderm, lung bud organoids and finally lung organoids. The organoids take ~40 d to generate and can be maintained more than 180 d, while progressively maturing up to a stage consistent with the second trimester of human gestation. They are unique because of their branching morphology, the near absence of non-lung endodermal lineages, presence of mesenchyme and capacity to recapitulate interstitial lung diseases. This protocol can be performed by anyone familiar with cell culture techniques, is conducted in serum-free conditions and does not require lineage-specific reporters or enrichment steps. We also provide a protocol for the generation of single-cell suspensions for single-cell RNA sequencing.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
scRNAseq data are available in the Gene Expression Omnibus database (Gene Expression Omnibus Submission (GSE215825), access code Urihimewhncrbql). The RNAseq datasets that support the findings of this study are from ref. 20, and available from the Sequence Read Archive. The Sequence Read Archive accession number for d25 LBOs sequencing is SRP073749 and SRR4295269 for d170 LBOs. Source data are provided with this paper.
References
Clevers, H. Modeling development and disease with organoids. Cell 165, 1586–1597 (2016).
McCauley, H. A. & Wells, J. M. Pluripotent stem cell-derived organoids: using principles of developmental biology to grow human tissues in a dish. Development 144, 958–962 (2017).
Miller, A. J. & Spence, J. R. In vitro models to study human lung development, disease and homeostasis. Physiology 32, 246–260 (2017).
Basil, M. C. et al. The cellular and physiological basis for lung repair and regeneration: past, present, and future. Cell Stem Cell 26, 482–502 (2020).
Herriges, M. & Morrisey, E. E. Lung development: orchestrating the generation and regeneration of a complex organ. Development 141, 502–513 (2014).
Basil, M. C. et al. Human distal airways contain a multipotent secretory cell that can regenerate alveoli. Nature 604, 120–126 (2022).
Habermann, A. C. et al. Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis. Sci. Adv. 6, eaba1972 (2020).
Kadur Lakshminarasimha Murthy, P. et al. Human distal lung maps and lineage hierarchies reveal a bipotent progenitor. Nature 604, 111–119 (2022).
Morrisey, E. E. & Hogan, B. L. Preparing for the first breath: genetic and cellular mechanisms in lung development. Dev. Cell 18, 8–23 (2010).
Burri, P. H. Fetal and postnatal development of the lung. Annu. Rev. Physiol. 46, 617–628 (1984).
Nikolić, M. Z., Sun, D. & Rawlins, E. L. Human lung development: recent progress and new challenges. Development 145, dev163485 (2018).
Herring, M. J., Putney, L. F., Wyatt, G., Finkbeiner, W. E. & Hyde, D. M. Growth of alveoli during postnatal development in humans based on stereological estimation. Am. J. Physiol. Lung Cell. Mol. Physiol. 307, L338–L344 (2014).
Dye, B. R. et al. A bioengineered niche promotes in vivo engraftment and maturation of pluripotent stem cell derived human lung organoids. eLife 5, e19732 (2016).
Dye, B. R. et al. In vitro generation of human pluripotent stem cell derived lung organoids. eLife 4, e05098 (2015).
Nikolic, M. Z. et al. Human embryonic lung epithelial tips are multipotent progenitors that can be expanded in vitro as long-term self-renewing organoids. eLife 6, e26575 (2017).
Dekkers, J. F. et al. Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis. Sci. Transl. Med. 8, 344ra84 (2016).
Salahudeen, A. A. et al. Progenitor identification and SARS-CoV-2 infection in human distal lung organoids. Nature 588, 670–675 (2020).
Lamers, M. M. et al. An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells. EMBO J. 40, e105912 (2021).
Jacob, A. et al. Differentiation of human pluripotent stem cells into functional lung alveolar epithelial cells. Cell Stem Cell 21, 472–488.e10 (2017).
Chen, Y. W. et al. A three-dimensional model of human lung development and disease from pluripotent stem cells. Nat. Cell Biol. 19, 542–549 (2017).
Carvalho, A. L. R. T. de et al. Glycogen synthase kinase 3 induces multilineage maturation of human pluripotent stem cell-derived lung progenitors in 3D culture. Development 146, dev171652 (2019).
Miller, A. J. et al. Generation of lung organoids from human pluripotent stem cells in vitro. Nat. Protoc. 14, 518–540 (2019).
Hawkins, F. J. et al. Derivation of airway basal stem cells from human pluripotent stem cells. Cell Stem Cell 28, 79–95.e8 (2021).
Gotoh, S. et al. Generation of alveolar epithelial spheroids via isolated progenitor cells from human pluripotent stem cells. Stem Cell Rep. 3, 394–403 (2014).
Masui, A., Hirai, T. & Gotoh, S. Perspectives of future lung toxicology studies using human pluripotent stem cells. Arch. Toxicol. 96, 389–402 (2022).
Konishi, S. et al. Directed induction of functional multi-ciliated cells in proximal airway epithelial spheroids from human pluripotent stem cells. Stem Cell Rep. 6, 18–25 (2016).
Porotto, M. et al. Authentic modeling of human respiratory virus infection in human pluripotent stem cell-derived lung organoids. mBio 10, e00723-19 (2019).
Strikoudis, A. et al. Modeling of fibrotic lung disease using 3D organoids derived from human pluripotent stem cells. Cell Rep. 27, 3709–3723.e5 (2019).
Green, M. D. et al. Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells. Nat. Biotechnol. 29, 267–272 (2011).
Huang, S. X. et al. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat. Biotechnol. 32, 84–91 (2014).
Roost, M. S. et al. KeyGenes, a tool to probe tissue differentiation using a human fetal transcriptional atlas. Stem Cell Rep. 4, 1112–1124 (2015).
Hogan, B. L. et al. Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function. Cell Stem Cell 15, 123–138 (2014).
Renzoni, E. A., Poletti, V. & Mackintosh, J. A. Disease pathology in fibrotic interstitial lung disease: is it all about usual interstitial pneumonia? Lancet 398, 1437–1449 (2021).
Lederer, D. J. & Martinez, F. J. Idiopathic pulmonary fibrosis. N. Engl. J. Med. 378, 1811–1823 (2018).
Katzen, J. & Beers, M. F. Contributions of alveolar epithelial cell quality control to pulmonary fibrosis. J. Clin. Invest. https://doi.org/10.1172/jci139519 (2020).
Armanios, M. Syndromes of telomere shortening. Annu. Rev. Genomics Hum. Genet. 10, 45–61 (2009).
Armanios, M. Telomerase mutations and the pulmonary fibrosis-bone marrow failure syndrome complex. N. Engl. J. Med. 367, 384 (2012).
Armanios, M. Y. et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 356, 1317–1326 (2007).
Garcia, C. K. Running short on time: lung transplant evaluation for telomere-related pulmonary fibrosis. Chest 147, 1450–1452 (2015).
Alder, J. K. & Armanios, M. Telomere-mediated lung disease. Physiol. Rev. https://doi.org/10.1152/physrev.00046.2021 (2022).
Kelich, J. et al. Telomere dysfunction implicates POT1 in patients with idiopathic pulmonary fibrosis. J. Exp. Med. 219, e20211681 (2022).
Dodson, L. M. et al. From incomplete penetrance with normal telomere length to severe disease and telomere shortening in a family with monoallelic and biallelic PARN pathogenic variants. Hum. Mutat. 40, 2414–2429 (2019).
Stuart, B. D. et al. Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening. Nat. Genet. 47, 512–517 (2015).
Petrovski, S. et al. An exome sequencing study to assess the role of rare genetic variation in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 196, 82–93 (2017).
Barkauskas, C. E. et al. Type 2 alveolar cells are stem cells in adult lung. J. Clin. Invest. https://doi.org/10.1172/JCI68782 (2013).
Moeller, A., Ask, K., Warburton, D., Gauldie, J. & Kolb, M. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int. J. Biochem. Cell Biol. 40, 362–382 (2008).
Matute-Bello, G., Frevert, C. W. & Martin, T. R. Animal models of acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 295, L379–L399 (2008).
Mulugeta, S., Nureki, S. & Beers, M. F. Lost after translation: insights from pulmonary surfactant for understanding the role of alveolar epithelial dysfunction and cellular quality control in fibrotic lung disease. Am. J. Physiol. Lung Cell Mol. Physiol. 309, L507–L525 (2015).
Florin, T. A., Plint, A. C. & Zorc, J. J. Viral bronchiolitis. Lancet 389, 211–224 (2017).
Firth, A. L. et al. Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells. Proc. Natl Acad. Sci. USA 111, E1723–E1730 (2014).
Yamamoto, Y. et al. Long-term expansion of alveolar stem cells derived from human iPS cells in organoids. Nat. Methods 14, 1097–1106 (2017).
Goss, A. M. et al. Wnt2/2b and beta-catenin signaling are necessary and sufficient to specify lung progenitors in the foregut. Dev. Cell 17, 290–298 (2009).
Chapman, D. L. et al. Expression of the T-box family genes, Tbx1-Tbx5, during early mouse development. Dev. Dyn. 206, 379–390 (1996).
McCauley, K. B. et al. Efficient derivation of functional human airway epithelium from pluripotent stem cells via temporal regulation of Wnt signaling. Cell Stem Cell 20, 844–857.e6 (2017).
Hawkins, F. et al. Prospective isolation of NKX2-1–expressing human lung progenitors derived from pluripotent stem cells. J. Clin. Invest. 127, 2277–2294 (2017).
Jacob, A. et al. Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells. Nat. Protoc. 14, 3303–3332 (2019).
Rodrigues Toste de Carvalho, A. L. et al. The in vitro multilineage differentiation and maturation of lung and airway cells from human pluripotent stem cell-derived lung progenitors in 3D. Nat. Protoc. 16, 1802–1829 (2021).
Kanagaki, S. et al. Directed induction of alveolar type I cells derived from pluripotent stem cells via Wnt signaling inhibition. Stem Cells 39, 156–169 (2021).
Rock, J. R. et al. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc. Natl Acad. Sci. USA 106, 12771–12775 (2009).
Butler, C. R. et al. Rapid expansion of human epithelial stem cells suitable for airway tissue engineering. Am. J. Respir. Crit. Care Med. 194, 156–168 (2016).
Huang, S. X. et al. The in vitro generation of lung and airway progenitor cells from human pluripotent stem cells. Nat. Protoc. 10, 413–425 (2015).
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902.e21 (2019).
Bergen, V., Lange, M., Peidli, S., Wolf, F. A. & Theis, F. J. Generalizing RNA velocity to transient cell states through dynamical modeling. Nat. Biotechnol. 38, 1408–1414 (2020).
Sherwood, R. I., Chen, T. Y. & Melton, D. A. Transcriptional dynamics of endodermal organ formation. Dev. Dyn. 238, 29–42 (2009).
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).
Hie, B., Bryson, B. & Berger, B. Efficient integration of heterogeneous single-cell transcriptomes using Scanorama. Nat. Biotechnol. 37, 685–691 (2019).
Acknowledgements
This work was supported by grants NIH HL120046 (H.-W.S.), NIH 1U01HL134760 (H.-W.S.), NIH S10 OD032447 (H.-W.S.), NIH 5T32HL105323 (R.T.S., principal investigator: J. Bhattacharya) and the Parker B. Francis Fellowship (Y.-W.C.), and by the Thomas R. Kully IPF Research Fund.
Author information
Authors and Affiliations
Contributions
Y.-W.C. originally developed the protocol and co-wrote the manuscript with H.-W.S., I.M.L. and R.T.S. played a key role in troubleshooting and perfecting the protocol. R.T.S. generated the images in Fig. 5. T.A.T. analyzed scRNAseq in collaboration with N.S. and K.B. who performed the scRNAseq, D.B. provided technical assistance, H.-Y.L. helped with optimizing and troubleshooting the protocol.
Corresponding authors
Ethics declarations
Competing interests
H.-W.S. and Y.-W.C. hold patents pertaining to the lung organoid technologies described. The other authors declare no competing interests.
Peer review
Peer review information
Nature Protocols thanks Shuibing Chen, Robert Hynds and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Related links
Key references using this protocol
Chen, Y. W. et al. Nat Cell Biol. 19, 542–549 (2017): https://doi.org/10.1038/ncb3510
Porotto, M. et al. mBio 10, e00723-19 (2019): https://doi.org/10.1128/mBio.00723-19
Strikoudis, A. et al. Cell Rep. 27, 3709–3723.e5 (2019): https://doi.org/10.1016/j.celrep.2019.05.077
Supplementary information
Supplementary Information
Supplementary Fig. 1.
Source data
Source Data Figs. 3a and 6
Raw data and statistical analysis.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Matkovic Leko, I., Schneider, R.T., Thimraj, T.A. et al. A distal lung organoid model to study interstitial lung disease, viral infection and human lung development. Nat Protoc 18, 2283–2312 (2023). https://doi.org/10.1038/s41596-023-00827-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41596-023-00827-6
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.